Display in USD
U.S. Department Of Health And Human Services Announces Availability Of Enforcement Discretion Policy Regarding 503a Compounding Using Certain Peptide Bulk Drug Substances; Will Not Enforce Against Pharmacies, Federal Facilities Or Physicians Compounding Drugs Using Peptide Bulk Substances Pending Rulemaking; Interim Policy Permits Peptide Compounding Pending Final Rulemaking On 503a Bulk Drug Substances List | WAPE